Ra Medical Systems to Report First Quarter 2022 Financial Results on May 16, 2022

Rhea-AI Summary

Ra Medical Systems (AMEX: RMED) will report its financial results for Q1 2022 on May 16, 2022, after market close. A conference call is scheduled for 1:30 p.m. PT to discuss these results and provide company updates. The DABRA excimer laser and catheters, manufactured in Carlsbad, California, are FDA-cleared for treating vascular diseases, including chronic total occlusions. The facility is ISO 13485 certified and licensed for manufacturing sterile catheters.

Positive

• DABRA laser and catheters are FDA-cleared for treating chronic total occlusions, indicating strong market potential.
• The manufacturing facility is ISO 13485 certified, ensuring high quality compliance.
• Upcoming conference call provides an opportunity for stakeholders to gain insights on financial performance.

Negative

• None.

CARLSBAD, Calif.--(BUSINESS WIRE)-- Ra Medical Systems, Inc. (NYSE American: RMED) announces that it will report financial results for the three months ended March 31, 2022 after market close on Monday, May 16. Ra Medical management will hold an investment community conference call that day at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) to discuss financial results and provide a company update.

Pre-Registration		Participants can pre-register for the conference call here:
		Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time.
Live Call:		Those who choose not to pre-register can access the live conference by dialing:
		U.S.	866-777-2509
		International	412-317-5413
		Request to join the Ra Medical Systems conference call
Live Webcast:		Ra Medical Systems Website
		The webcast will be archived for 30 days.
Replay:		U.S.	877-344-7529
		Canada	855-669-9658
		International	412-317-0088
		Passcode	6866135
		The replay will be available for 48 hours

About Ra Medical Systems

Ra Medical Systems manufactures the DABRA excimer laser and catheters for the treatment of certain vascular diseases. DABRA has been cleared by the FDA for crossing chronic total occlusions in patients with symptomatic infrainguinal lower extremity vascular disease and has an intended use for ablating a channel in occlusive peripheral vascular disease. In addition, DABRA has been granted CE mark clearance for the endovascular treatment of infrainguinal arteries via atherectomy and for crossing total occlusions. DABRA excimer lasers and catheters are manufactured in a 32,000-square-foot facility located in Carlsbad, California. The vertically integrated facility is ISO 13485 certified and is licensed by the State of California to manufacture sterile, single-use catheters in clean room environments.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220509005023/en/

At the Company:

Andrew Jackson

Chief Financial Officer, Ra Medical Systems

760-496-9540

ajackson@ramed.com

Investors:

LHA Investor Relations

Jody Cain

310-691-7100

jcain@lhai.com

Source: Ra Medical Systems, Inc.

FAQ

When will Ra Medical Systems report its Q1 2022 financial results?

Ra Medical Systems will report its Q1 2022 financial results on May 16, 2022, after market close.

What time is the earnings conference call for Ra Medical Systems?

The earnings conference call for Ra Medical Systems is scheduled for 1:30 p.m. Pacific Time on May 16, 2022.

What products does Ra Medical Systems manufacture?

Ra Medical Systems manufactures the DABRA excimer laser and catheters for treating certain vascular diseases.

Where is Ra Medical Systems' manufacturing facility located?

The manufacturing facility of Ra Medical Systems is located in Carlsbad, California.